Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Mar;41(3):164-72.

Naltrexone/Bupropion ER (Contrave): Newly Approved Treatment Option for Chronic Weight Management in Obese Adults

Naltrexone/Bupropion ER (Contrave): Newly Approved Treatment Option for Chronic Weight Management in Obese Adults

Matthew M Sherman et al. P T. 2016 Mar.

Abstract

Naltrexone/bupropion ER (Contrave): newly approved treatment option for chronic weight management in obese adults.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Structural Formula of Naltrexone (A) and Bupropion (B)

References

    1. Ogden CL, Carroll MD, Kit BK, Flegal KM. Prevalence of childhood and adult obesity in the United States, 2011–2012. JAMA. 2014;311(8):806–814. doi: 10.1001/jama.2014.732. - DOI - PMC - PubMed
    1. Centers for Disease Control and Prevention Defining overweight and obesity. 2012. Available at: www.cdc.gov/obesity/adult/defining.html. Accessed January 1, 2015.
    1. Centers for Disease Control and Prevention Adult obesity facts. 2014. Available at: www.cdc.gov/obesity/data/adult.html. Accessed January 1, 2015.
    1. National Cancer Institute Obesity and cancer risk. 2012. Available at: www.cancer.gov/cancertopics/factsheet/Risk/obesity. Accessed January 1, 2015.
    1. Finkelstein EA, Trogdon JG, Cohen JW, Dietz W. Annual medical spending attributable to obesity: payer- and service-specific estimates. Health Aff. 2009;28(5):822–831. doi: 10.1377/hlthaff.28.5.w822. - DOI - PubMed